Skip to main content

Animations

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2655${count})

  • Research Grant, 2026
    A Patient Reported Outcome Assessment for Patients with Early Parkinson’s Disease

    Study Rationale:                   

    There are no validated tools to assess functional changes in people living with PD (PwP) at the earliest clinical stages. Available tools lack sufficient sensitivity...

  • ASAP CRN 2025 RFA Scientific Track, 2026
    Ventral Tegmental Area Dopamine Neuron Subtype-Specific Roles in Parkinson's Disease-Related Cognitive Symptoms
    ASAP logo

    Study Rationale:                         

    Parkinson’s Disease (PD) patients have difficulty in key components of cognition, such as the ability to estimate time intervals as well as learn from negative...

  • ASAP CRN 2025 RFA Scientific Track, 2026
    Mitochondrial Surface as a Neuroprotective Signal Integrator in PD
    ASAP logo

    Study Rationale:                         

    Accumulation of damage to the cellular batteries (mitochondria) in the brain is a major driver of PD. Analysis of two genes PINK1 and PARKIN have provided...

  • ASAP CRN Discovery Fellowship 2025, 2026
    Does Pathogenic α-Synuclein Disrupt Lipid Droplet–Mitochondria Coupling in Parkinson’s Disease?
    ASAP logo
  • ASAP CRN Discovery Fellowship 2025, 2026
    Parsing the Diverse Neuromodulation of Vulnerable Versus Resistant Dopamine Axons According to Distinct Molecular Subtype
    ASAP logo

    Study Rationale:                         

    Dopamine is a critical signaling molecule in the brain for voluntary movement. Neurons that produce and release dopamine are lost in Parkinson’s disease...

  • ASAP CRN Discovery Fellowship 2025, 2026
    Untangling PINK1–Tau Crosstalk and Co-Morbidity Mechanisms in Parkinson’s Disease

    Study Rationale:                         

    Parkinson’s disease is a brain disorder that gets worse over time, causing problems with movement and cognitive abilities. Two key problems are often seen...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.